---
document_datetime: 2023-09-21 19:09:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_en.pdf
document_name: raptiva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.742705
conversion_datetime: 2025-12-19 02:17:10.176826
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented   | Strength   | Pharmaceutical Form                           |
|-----------------|------------|------------|-----------------------------------------------|
| EU/1/04/291/001 | Raptiva    | 100 mg/ml  | Powder and solvent for solution for injection |
| EU/1/04/291/002 | Raptiva    | 100 mg/ml  | Powder and solvent for solution for injection |
| EU/1/04/291/003 | Raptiva    | 100 mg/ml  | Powder and solvent for solution for injection |

Subcutaneous use

Subcutaneous use

Subcutaneous use

<!-- image -->

1 vial + 1 pre-filled syringe + 2 needles 4 vials + 4 pre-filled syringes + 8 needles 12 vials + 12 pre-filled syringes + 24 needles

Medicinal product no longer authorised 1/1 Route of Administration Packaging Package size Powder: vial (glass); solvent: prefilled syringe (glass) Powder: vial (glass); solvent: prefilled syringe (glass) Powder: vial (glass); solvent: prefilled syringe (glass)